文献速递免疫规划传染病防控与疫情报告

中空微针改善小鼠皮内接种剂量一致性:SARS-CoV-2 mRNA疫苗模型研究

Improving intradermal dosing consistency in mice using a hollow microneedle: A model study with a SARS-CoV-2 mRNA vaccine.
PubMed 文献 · Vaccine · 2026-09-05

本研究以小鼠为模型,通过量化背部皮肤厚度随年龄变化,开发捏皮式施加器、小鼠中空微针及插入器以标准化皮褶厚度与插入深度,改善皮内给药一致性。在雄性C57BL/6J小鼠中比较肌内与皮内接种SARS-CoV-2 spike mRNA-LNP疫苗,皮内组可测得抗RBD IgG应答,且spike特异性细胞因子阳性CD8a+ T细胞较肌内组有增加趋势但差异无统计学意义。

要点

  • 皮肤厚度引导控制捏皮直径可显著改善小鼠皮内递送可行性。
  • 该平台标准化皮褶厚度与插入深度,提高皮内给药一致性。
  • 同剂量下皮内接种诱导可测抗RBD IgG,CD8a+ T细胞有增加趋势但未达统计学显著。

核心结论

  • 该平台改善了小鼠皮内给药一致性,并支持标准免疫原性与免疫亚群分析。
  • 支持将皮内途径纳入小动物疫苗与治疗药物概念验证研究。

研究设计与样本

  • 小鼠模型临床前研究,量化背部皮肤厚度年龄相关变化并开发捏皮式施加器、中空微针及插入器。
  • 雄性C57BL/6J小鼠间隔2周免疫两次,比较肌内与皮内多剂量水平接种SARS-CoV-2 spike mRNA-LNP疫苗。
  • 加强免疫后2周评估固定血清稀释度下抗RBD IgG应答与spike特异性细胞应答。

主要发现

  • 手动卡尺测量的皮褶厚度随年龄变化,而冷冻切片测量的皮肤外表面至真皮-皮下脂肪交界厚度仅轻度变化。
  • 皮肤厚度引导控制捏皮直径明显改善皮内递送可行性,并在接种前于雄性C57BL/6J小鼠中确认流程可行性。
  • 皮内接种诱导可测抗RBD IgG应答。
  • 同剂量下皮内较肌内接种spike特异性细胞因子阳性CD8a+ T细胞有增加趋势,但差异无统计学意义。

临床怎么用

  • 在小动物疫苗概念验证研究中可采用皮肤厚度引导的捏皮与中空微针插入标准化皮内接种。
  • 皮内途径可作为肌内途径之外的免疫原性与免疫亚群分析选项。

局限性

  • 皮内与肌内接种间spike特异性CD8a+ T细胞差异未达统计学显著。
  • 研究为小鼠临床前模型,结论外推至其他物种或临床需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intradermal vaccination can enhance immune responses, yet reproducible intradermal injection remains technically challenging, particularly for hollow microneedle delivery. Herein, using a mouse model, we aimed to establish a preclinical platform that enables more consistent intradermal vaccine delivery. We quantified age-dependent changes in mouse dorsal skin thickness and developed a pinch-type applicator, a hollow microneedle for mice, and an inserter to stabilize the skin and standardize effective skinfold thickness and insertion depth. Skinfold thickness measured using manual calipers varied with age, whereas cryosection-based measurements of the skin layer thickness from the outer surface to the dermal-subcutaneous adipose tissue interface showed only modest variations, indicating that visible age-related changes largely reflect skinfold structure. Skin-thickness-guided control of the pinching diameter markedly improved intradermal deliverability, and the feasibility of this process was confirmed in male C57BL/6J mice before vaccination. The mice were immunized twice at 2-week intervals with an mRNA-lipid nanoparticle (mRNA-LNP) vaccine encoding SARS-CoV-2 spike, delivered intramuscularly or intradermally at multiple dose levels; anti-receptor-binding domain (RBD) IgG responses measured at a fixed serum dilution and spike-specific cellular responses were evaluated 2 weeks post-boost. Intradermal administration induced measurable anti-RBD IgG responses and showed a tendency toward increased spike-specific cytokine-positive CD8a+ T cells compared with intramuscular dosing at the same dose, although this difference was not statistically significant. Collectively, this platform improved intradermal dosing consistency in mice and supported standard immunogenicity and immune-subset analyses, supporting incorporation of the intradermal route into small-animal proof-of-concept studies for the development of vaccines and therapeutics.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Onishi S, Suzuki Y, Sugimoto K, et al. Improving intradermal dosing consistency in mice using a hollow microneedle: A model study with a SARS-CoV-2 mRNA vaccine. Vaccine. 2026. PMID: 42700750. doi:10.1016/j.vaccine.2026.129111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。